A study of 9 000 women with established cardiovascular disease has found that mortality is reduced by 25 per cent among those taking aspirin, and that the dose of daily aspirin does not affect this result. Jeffrey Berger of Duke University Medical Center told us more about it.
[audio:https://www.audiomedica.com/podcasting/aha2005/Jeffrey_Berger.mp3]
Fondaparinux: Better than Enoxaparin for Patients with Acute Coronary Syndromes? 12 Sep, 2005 Audio Journal of Cardiovascular Medicine 11.2, 2005 8 Jan, 2006 Endeavor: Alternative Drug-Eluting Stent? 12 Sep, 2005 Looking for Atherosclerosis in the Legs Could Save Lives 5 Sep, 2007 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014